MAPT and supranuclear palsy, progressive, 1: As an additional control group for AD dementia, we also analyzed several tau isoforms in postmortem retinas of patients with non-AD dementia (n = 4), including DLB, FTLD with ALS, FTLD-tauopathy with Pick’s disease, and FTLD-tauopathy with PSP (see Methods above and Suppl.